Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aortic Valve Stenosis
|
19 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Atrial Fibrillation
|
584 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Body Height
|
3972 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
Body mass index
|
2689 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Cardiovascular Diseases
|
711 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Cerebrovascular accident
|
591 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Coronary Arteriosclerosis
|
440 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Coronary Artery Disease
|
1577 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||
Coronary heart disease
|
1178 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.830 | 1.000 | 5 | 2011 | 2019 | |||||
Diabetes
|
710 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Diabetes Mellitus
|
824 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Diastolic blood pressure
|
1037 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Dyslipidemias
|
184 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
elevated blood glucose level
|
111 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.800 | 1.000 | 2 | 2011 | 2016 | |||||
Glucose measurement
|
111 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.800 | 1.000 | 2 | 2011 | 2016 | |||||
Heart failure
|
201 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Hematocrit procedure
|
216 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
High density lipoprotein measurement
|
1440 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.800 | 1.000 | 4 | 2009 | 2019 | |||||
Hyperlipidemia
|
83 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Ischemic stroke
|
704 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Lipids measurement
|
53 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.800 | 1.000 | 2 | 2012 | 2016 | |||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Major Depressive Disorder
|
1451 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Malignant Neoplasms
|
1641 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Metabolic Syndrome X
|
591 | 0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 | 0.020 | 1.000 | 2 | 2019 | 2019 |